Review
Open access
Sep 2026
High-Risk Dyslipidemia: Lipid targets, high-intensity statins, and novel lipid-lowering agents
High-risk dyslipidemia is a treatment problem defined less by an isolated cholesterol value than by the interaction between atherogenic lipoprotein burden and absolute cardiovascular risk. This structured narrative review examines contemporary lipid targets, the role of high-intensity statins, and the place of newer li...
F. D. de Souza, Laura Leme de Araújo Rodrigues da Silva, Nicolas Victor Camargo Chon et al.
· International Health Science... · 0 citations